Terms: = Prostate cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
12 results:
1. A Model for Gastric cancer Risk Prediction Based on
Nguyen NT; Dang NDT; Vu QV; Dang AK; Ta TV
In Vivo; 2023; 37(5):2347-2356. PubMed ID: 37652501
[TBL] [Abstract] [Full Text] [Related]
2. The role of epithelial membrane antigen (ema) overexpression in the prognosis of prostatic adenocarcinoma.
Ghalib R; Falah A
J Med Life; 2022 Apr; 15(4):504-508. PubMed ID: 35646176
[TBL] [Abstract] [Full Text] [Related]
3. Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups.
Alshaker H; Mills R; Hunter E; Salter M; Ramadass A; Skinner BM; Westra W; Green J; Akoulitchev A; Winkler M; Pchejetski D
J Transl Med; 2021 Jan; 19(1):46. PubMed ID: 33509203
[TBL] [Abstract] [Full Text] [Related]
4. BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.
Shrestha R; Nabavi N; Lin YY; Mo F; Anderson S; Volik S; Adomat HH; Lin D; Xue H; Dong X; Shukin R; Bell RH; McConeghy B; Haegert A; Brahmbhatt S; Li E; Oo HZ; Hurtado-Coll A; Fazli L; Zhou J; McConnell Y; McCart A; Lowy A; Morin GB; Chen T; Daugaard M; Sahinalp SC; Hach F; Le Bihan S; Gleave ME; Wang Y; Churg A; Collins CC
Genome Med; 2019 Feb; 11(1):8. PubMed ID: 30777124
[TBL] [Abstract] [Full Text] [Related]
5. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
Liang X; Li Z; Men Q; Li Y; Li H; Chong T
Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
[TBL] [Abstract] [Full Text] [Related]
6. The aspirin metabolite salicylate inhibits lysine acetyltransferases and muc1 induced epithelial to mesenchymal transition.
Fernandez HR; Lindén SK
Sci Rep; 2017 Jul; 7(1):5626. PubMed ID: 28717171
[TBL] [Abstract] [Full Text] [Related]
7. Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.
Okamoto T; Yoneyama MS; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Fukuda M; Ohyama C; Tsuboi S
Mol Med Rep; 2013 Feb; 7(2):359-64. PubMed ID: 23165940
[TBL] [Abstract] [Full Text] [Related]
8. Influence of muc1 genetic variation on prostate cancer risk and survival.
Strawbridge RJ; Nister M; Brismar K; Li C; Lindström S
Eur J Hum Genet; 2008 Dec; 16(12):1521-5. PubMed ID: 18628787
[TBL] [Abstract] [Full Text] [Related]
9. Micropapillary component of urothelial carcinoma detected in transurethral resection of bladder tumor (TUR-BT) tissues: a case report.
Ohtsuki Y; Ochi K; Okada Y; Kato M; Lee GH; Furihata M
Med Mol Morphol; 2008 Jun; 41(2):113-6. PubMed ID: 18592166
[TBL] [Abstract] [Full Text] [Related]
10. Expression of sialylated muc1 in prostate cancer: relationship to clinical stage and prognosis.
Arai T; Fujita K; Fujime M; Irimura T
Int J Urol; 2005 Jul; 12(7):654-61. PubMed ID: 16045558
[TBL] [Abstract] [Full Text] [Related]
11. [Tumor infiltrating dendritic cells and Mucin1 gene expression in benign prostatic hyperplasia and prostate cancer].
Xiang ST; Zhou SW; Guan W; Wang QZ; Zhang B; Liu JH; Ye ZQ
Zhonghua Nan Ke Xue; 2003 Oct; 9(7):497-500. PubMed ID: 14628595
[TBL] [Abstract] [Full Text] [Related]
12. [Relation between neuroendocrine expression of prostatic carcinoma and prognosis].
Huang ZY; Meng FQ; Chen H
Zhonghua Yi Xue Za Zhi; 1994 Jan; 74(1):23-5, 62-3. PubMed ID: 8032980
[TBL] [Abstract] [Full Text] [Related]
